PRME
Prime Medicine·NASDAQ
--
--(--)
--
--(--)
Prime Medicine (PRME) Company Profile
Prime Medicine, Inc.
A biotechnology company that focused on cure genetic disorders by deploying Prime Editing technology
60 First Street, Cambridge, MA 02141
Develops gene editing therapies.
Prime Medicine, Inc., was incorporated in Delaware in September 2019. The company is a biotechnology company dedicated to delivering a new class of differentiated one-time therapeutic gene therapies — Prime Editors, which address the broadest spectrum of diseases by deploying Prime Editing technology.
